Search results
Moderna’s New Covid-19 Vaccine Shows Positive Results
Barrons.com· 3 days agoShares of Moderna were down 0.2% Tuesday to $110.12. The stock has gained 11% this year. Shares of...
Moderna’s new and improved COVID vaccine produced positive trial results
Market Watch· 3 days ago“MRNA-1283 is a critical component of our combination vaccine against flu and COVID-19, mRNA-1083,...
Moderna unveils robust next-gen COVID-19 vaccine pipeline progress By Investing.com
Investing.com· 2 days agoThe company expects regulatory approval and U.S. launch for its RSV vaccine in 2024, following...
Moderna Gets $750 Million for Flu Program to Help Move Beyond Covid Vaccines
Barrons.com· 2 days ago“Our goal is to launch multiple vaccine products in the next few years and deliver the greatest...
Moderna's next-gen COVID-19 vaccine shows higher immune response By Investing.com
Investing.com· 3 days agoModerna , Inc. (NASDAQ:MRNA) reported on Monday that its next-generation COVID-19 vaccine,...
Moderna Says 'Next-Generation' COVID-19 Shot Had Positive Phase 3 Test Results
Investopedia· 3 days agoChief Executive Officer (CEO) Stephane Bancel explained that mRNA-1283 is a “critical component” of...
AI could revolutionise healthcare – here’s how to cash in
The Telegraph via Yahoo News· 2 days agoIn February 2023 at a concert in Dubai, world renowned DJ David Guetta, used artificial intelligence...
Moderna gets Blackstone backing for flu vaccine R&D
BioPharma Dive via Yahoo Finance· 2 days ago“Our goal is to launch multiple vaccine products in the next few years and deliver the greatest possible impact to people through mRNA medicines,” said ...
Moderna's Next Gen COVID Vaccine Meets Primary Goal In Late-Stage Trial - Moderna (NASDAQ:MRNA)
Benzinga· 3 days ago“We are excited to announce our fourth infectious disease vaccine program with positive Phase 3 data, further validating our robust mRNA platform,” said Stéphane ...
Blackstone to invest up to $750 million in Moderna to develop new vaccines - The Boston Globe
The Boston Globe· 2 days agoBlackstone Life Sciences, a private investment company, is making a big bet on its Cambridge...